The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated ...

Both the retina as a whole and separate retinal layers had a reduction in retinal thickness after the use of anti-vascular endothelial growth factor (VEGF) treatments. Retinal thickness was ...

Please provide your email address to receive an email when new articles are posted on . The American Heart Association issued a scientific statement with recommendations for the diagnosis, treatment ...

Please provide your email address to receive an email when new articles are posted on . Continuous growth of macular neovascularization size, as well as development of outer retina atrophy, was ...

New research shows that a treatment for retinal vein occlusion yields long-lasting vision gains, with visual acuity remaining significantly above baseline at five years. However, many patients require ...

Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are the leading causes of vision impairment in elderly patients and people living with diabetes, respectively.